Neuroendocrine regulation of metabolism and reproduction are tightly interlinked. Nesfatin-1 is an 82 amino acid metabolic peptide derived from nucleobindin-2 (NUCB2). NUCB2 mRNA and protein significantly increase in the hypothalamus of rats during puberty-to-adult transition. Administration of nesfatin-1 modulates circulating LH and testosterone in male rats. However, whether nesfatin-1 acts directly on neurons and gonadotropes remain unknown. In addition, whether reproductive hormones of the hypothalamo-pituitary gonadal axis modulate NUCB2/nesfatin-1 is unclear. To address these, we employed murine hypothalamic (GT1-7) and pituitary (LβT2) cells in vitro. Nucb2 expression, and NUCB2/nesfatin-1 immunoreactivity were observed in both GT1-7 and LβT2 cells, and in the hypothalamus of mice. Nesfatin-1 co-localized GnRH in GT1-7 cells, and in the hypothalamic perikarya of mice. Cells were treated with kisspeptin, GnRH, and estradiol and testosterone, as well as nesfatin-1 for 2, 6 or 24 hours. Synthetic nesfatin-1 increased Kiss1r and Gnrh expression in GT1-7 cells and Lhβ in LβT2. Nesfatin-1 increased GnRH and LHβ protein expression in GT1-7 and LβT2 at 6-hour post incubation respectively. Both NUCB2 mRNA and protein were increased in GT1-7 cells treated with kisspeptin. Testosterone increased NUCB2 mRNA and protein expression in GT1-7 and LβT2. 17β-estradiol increased NUCB2 mRNA and protein expression in LβT2. Nesfatin-1 acts directly on hypothalamic neurons and gonadotropes to elicit a generally positive influence on the endocrine milieu regulating reproduction in mice. Reproductive hormones, in turn, modulate brain and pituitary NUCB2/nesfatin-1. In conclusion, we provide additional information to designate nesfatin-1 as a novel, additional factor that helps reproductive success. 
Introduction
Energy balance and reproduction are tightly interlinked [1] [2] [3] [4] . It has been demonstrated that metabolic hormones are indispensable for fertility [5, 6] . Major metabolic diseases, including obesity and diabetes, result in severe reproductive defects [7] . However, the hormones interconnecting metabolism and reproduction are not fully elucidated. Hormones that modulate both metabolic and reproductive functions are on the rise. For instance, adipokine leptin increases pulsatile gonadotropin-releasing hormone (GnRH) secretion [8] . Leptin deficiency causes reproductive malfunctions and sterility [9] . Receptors for the hunger hormone ghrelin are expressed in gonads [5, 10] . Ghrelin modulates reproductive functions via inhibition of GnRH release, and attenuates LH response to GnRH and kisspeptin [11] [12] [13] . These observations suggest that both orexigenic and satiety signals are directly responsible for the modulation of reproductive axis.
Nesfatin-1 is an 82-amino-acid orphan ligand encoded by the secreted precursor nucleobindin-2 (NUCB2). Nesfatin-1 is expressed in the lateral hypothalamic area (LHA), paraventricular nucleus (PVN), supraoptic nucleus (SON), and arcuate nucleus (ARC) of both rats and mice [14] [15] [16] [17] 36] . Nesfatin-1 also colocalizes pro-opiomelanocortin (POMC), cocaine-and amphetamineregulated transcript (CART), oxytocin and neuropeptide Y (NPY); neuropeptides known for their role in the regulation of appetite [15, 18, 19] . Nesfatin-1 regulates glucose metabolism, insulin secretion [18, [20] [21] [22] [23] , gastrointestinal motility [24] , stress response [25] , development [26] [27] [28] cardiovascular functions [29] , anxiety [30] , and onset of puberty [14] . Expression of nesfatin-1 in testicular Leydig cells, and ovarian theca cells were recently reported [14, [31] [32] [33] [34] 36] . This suggests a role for nesfatin-1 in the modulation of reproductive functions.
In support of this, autoradiographic studies using 125 I-labeled nesfatin-1 showed appreciable signal intensity in rat testis [35] . Nesfatin-1 binding sites were determined in the pituitary and different parts of brain including cortex and PVN of the hypothalamus, cerebellum, area postrema (AP) and dorsomedial nucleus (DMN) [35] . The interplay between nesfatin-1, gonadotropin, and gonadal steroids was highlighted recently. Gonadotropin injection increases NUCB2/nesfatin-1 expression in testis and epididymis in mice [33] and nesfatin-1 intracerebroventricular (i.c.v.) injection increases circulating luteinizing hormone (LH) in male and female rats [14, 31] . I.c.v. injection of nesfatin-1 decreased serum T, LH, and folliclestimulating hormone (FSH) levels in pubertal and adult male rats, along with downregulation of hypothalamic Kiss1, Gnrh, and Lh expression [36] . On the other hand, incubation of rat Leydig cells with nesfatin-1 increased serum T level after 24 h [36] . The reasons for these discordant results are currently unknown. Central injections of anti-NUCB2 morpholino oligonucleotides during pubertal maturation delays vaginal opening, decreases ovarian weight, and reduces circulating LH levels in pubertal female rats [14] . These results strongly support interplay between nesfatin-1 and sex steroid hormones. These findings indicate a significant role for nesfatin-1 in the neuroendocrine regulation of hypothalamo-pituitary-gonadal (HPG) axis. However, it remains unclear whether nesfatin-1 acts directly on the brain and pituitary to modulate reproductive hormones. The possible actions of GnRH, kisspeptin, gonadotropins, and gonadal steroids to regulate nesfatin-1/NUCB2 in the brain and pituitary are also currently unclear.
We hypothesize that nesfatin-1 acts directly on hypothalamic neurons and gonadotropes to modulate GnRH, Kiss1/Kiss1R, and gonadotropins (LHβ/FSHβ), and that reproductive hormones in turn regulate NUCB2/nesfatin-1 in the brain and pituitary. We tested these hypotheses using murine immortalized hypothalamic GnRHsecreting neurons and immortalized gonadotrope-derived LβT2 cells in vitro.
Materials and methods

GT1-7 and LβT2 cells culture and maintenance
GT1-7 and LβT2 immortalized murine hypothalamus and anterior pituitary cells were kindly provided by Dr Pamela L. Mellon, University of California (San Diego, CA). GT1-7 and LβT2 cell lines were cultured in complete Dulbecco modified essential medium (DMEM) containing 4.5 g/L of glucose, supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (Pen-Strep; Gibco) in a humidified environment with 95% O 2 and 5% CO 2 at 37
• C.
The culture medium was changed twice a week, and cultures were passaged at ∼90% confluency every 6 days. Cells under passages between 7 and 12 were used in these experiments. One day after splitting cells into 12-well plates (2 × 10 5 viable cells/well, mRNA expression) or 6-cm plates (western blotting), the cells were starved in media containing 1% FBS. After overnight incubation, 1% FBS-DMEM was removed, and plates were incubated with serum-free DMEM containing either peptide or ethanol vehicle. To determine the effects of peptides and hormones on mRNA and protein expression, the cells were exposed to 0, 1, 10, and 100 nM rat synthetic nesfatin-1 (sequence: VPIDVDKTKVHNVEPPESARIEPPDTGLYYDEYLKQVIEVLETD PHFREKLQKADIEEIRSGRLSQELDLVSHKVRTRLDEL-OH (Abgent, CA; >95% purity), human GnRH peptide (product no. ab41769; Abcam, MA), kisspeptin-10 (product no. H-5544; Bachem), 17β-estradiol (product no. E2758; Sigma), testosterone (product no. T1500; Sigma), or vehicle (0.001% ethanol). Cells were harvested 2, 6, and 24 h after the initiation of treatment. Cells were washed in phosphate-buffered saline (PBS) and collected for total RNA and/or protein extraction.
Total RNA extraction, cDNA synthesis, RT-PCR, and real-time quantitative PCR Total RNA was extracted using TRIzol RNA isolation reagent (product no: 15596-026; Invitrogen, Carlsbad, CA). The concentration of total RNA was measured using a Nanodrop (Nanodrop2000), and RNA quality was verified using the A260 nm/A280 nm (>1.8) and A230 nm/A260 nm (>2) ratios. Total RNA (1 μg) was subjected • C and the absence of any dimer formation or artifacts was confirmed. The relative mRNA expression of target genes was normalized against beta-actin, as a reference gene, using a comparative cycle threshold (Ct) method (2− Ct) [37] . Results are expressed as a fold of expression in untreated cells at each treatment time.
Western blot analysis
Western blot analyses were conducted on protein collected from cells treated for 6 h with peptides. After 6-h incubation with the chosen concentrations of peptides tested, cells were solubilized in 100 μL RIPA buffer (product no: 89901, Thermo Scientific, Rockford, lL) according to the manufacturer's protocols. Briefly, cells were washed twice with cold PBS. Ice-cold RIPA buffer (100 μl) with proteinase inhibitor cocktail was then added to each well. The lysate were centrifuged at ∼14,000 × g for 15 min to pellet the cell debris. Protein concentration was quantified using a Pierce BCA (bicinconchinic acid) protein assay kit (Pierce Biochemicals, Rockford, IL). Aliquot of 25 (GT1-7) or 40 (LβT2) μg protein prepared in 1X Laemmli buffer containing 5% 2-mercaptoethanol (product no. 161-0737 and -0710; Bio-Rad) were loaded on to Mini-PROTEAN TGX 4%-20% gradient gel (product no. 456-1096; Bio-Rad) and were run under constant voltage (200 V) conditions for 30 min followed by transferring onto a 0.2 μm nitrocellulose membrane using the TransBlot Turbo system (product no: 170-4155) and Trans-Blot Turbo RTA Mini Nitrocellulose Transfer Kit (product no: 1704270; BioRad). Membranes were blocked in 1X RapidBlock solution (product no. M325; aMReSCO) for 5 min and were incubated overnight with Rabbit anti-NUCB2 antibody (1:1000, product no. 1312-PAC-01 custom antibody, Pacific Immunology) or rabbit anti-vinculin antibody (1:3000, product no. Ab73412; Abcam, Inc.) or rabbit polyclonal anti-GnRH antibody (1:1000 dilution; product no: ab5617; Abcam, Inc.) or rabbit polyclonal anti-LH beta antibody (1:1000 dilution; product no. ab180787; Abcam, Inc.) Subsequently, membranes were incubated with goat anti-rabbit (H+L) Horse Radish Peroxidase conjugated (IgG) (1:3000 dilution; product no.170-6515; Bio-Rad) or goat anti-mouse IgG (H+L) HRP conjugate (1:3000 dilution; product no. 171-1011; Bio-Rad) secondary antibody for 1 h. Visualization was performed by incubating membrane for 5 min in Clarity Western ECL substrate (product no.170-5061; Bio-Rad) and imaged using ChemiDoc MP imaging system (product no.170-8280; Bio-Rad) with chemiluminescence detection. Precision plus protein dual Xtra standards (product no.161-0377; Bio-Rad) were used as molecular weight markers. Quantification of the bands was performed by Image J software (PC-based open source software).
Immunocytochemistry, immunohistochemistry, and immunofluorescence microscopy GT1-7 and LβT2 cells were cultured in DMEM using chamber slides (Nalge Nunc Int, Naperville, IL). Upon 60% confluence, cells were washed with PBS and were fixed with 4% paraformaldehyde (PFA) (pH 7.4) for 10 min and permeabilized for 10 min with 0.2% Triton X-100 in PBS at room temperature. The slides were then incubated in 2% goat serum for 30 min to block nonspecific binding of the antibody. The cells were then incubated with rabbit anti-NUCB2 antibody (1:200 dilution; product no. 1312-PAC-01 custom antibody; Pacific Immunology) overnight at 4
• C and washed thrice with PBS, followed by Alexa Fluor 594 Goat anti-rabbit IgG (product no. R37117; Invitrogen Corp.) in a humidified chamber for 1 h and washed with PBS. Slides were then mounted using Vectashield mounting medium containing the DAPI nuclear fluorescent dye (Blue; Vector Laboratories, Burlingame, CA). Slides were then imaged using a Nikon inverted microscope (L100) (Nikon, Canada) using the NiS Elements microscope imaging software (Nikon). Rabbit polyclonal anti-NUCB2 antibody used in this study was validated and used for staining of intestinal (STC-1) cells [42] . Both preabsorption control and no-primary antibody-negative controls showed no immunofluorescence, confirming the specificity of the antibody used [42] .
Immunohistochemical analysis was performed as described previously [26] . Briefly, mouse hypothalamus was collected and fixed in 4% PFA for 24 h at 4˚C. Tissues were then stored in 70% ethanol at 4˚C and were processed and sectioned at the Prairie Diagnostic Services Inc. (PDS Inc., Western College of Veterinary Medicine, University of Saskatchewan). Paraffin sections of 4 μm thickness were prepared for immunostaining. These sections were deparaffinized with xylene and rehydrated in a graded ethanol series. The sections were then blocked with serum-free protein block reagent (DAKO Corporation, CA) for 10 min, and then incubated with rabbit anti-NUCB2 antibody (1:500 dilution; product no. 1312-PAC-01 custom antibody; Pacific Immunology) and mouse antiGnRH antibody (1:500 dilution; product no. Ab76560; Abcam) overnight at 4
• C. Following this, slides were washed thrice with PBS, and incubated with secondary antibodies, goat anti-rabbit Texas Red IgG (Red-Nesfatin-1; 1:500 dilution; product no. TI-1000; Vector Laboratories) and goat polyclonal anti-mouse FITC IgG (H & L) (green-GnRH; 1:500 dilution; product no. Ab6785; Abcam) for 1 h at room temperature and washed with 1X PBS. Slides were mounted and imaged as described earlier [39] .
Localization of nucleobindin-2 expression in mouse hypothalamus by in situ hybridization
Sense and antisense RNA probes for mouse NUCB2 were generated as per the manufacturer's instructions by in vitro transcription of the linearized DNA using FISH Tag RNA Multicolor Kit (Invitrogen) employing T7 and SP6 polymerases. Probes were synthesized from the NUCB2 PCR product cloned using a PGEM-T easy vector.
Mouse hypothalamus was fixed overnight in 4% (v/v) PFA in PBS at 4
• C. After fixation, tissues were embedded and sectioned serially at a thickness of 5 μm. Prior to in situ hybridization (ISH), sections were deparaffinized and dehydrated in 100% ethanol and air-dried. Slides were pretreated with Formalin-Fixed Paraffin-Embedded FISH pretreatment kit (product no. KA2375 V 1.0; Abnova, Walnut, CA). Briefly, slides were treated in 1X paraffin pretreatment solution at 95
• C for 30 min and then in saline-sodium citrate buffer (SSC) for 5 min twice and treated with protease solution (pepsin, 1 μl/ml) for 10 min at 37
• C. After washing in SSC, sections were subsequently dehydrated through ethanol series, and air-dried. Sections were then hybridized (FISH hybridization buffer, product no. U0028; Abnova) with sense and antisense fluorescent labeled RNA probes (1 ng/μl) for 24 h at 37
• C, after a 5 min denaturation at 75
• C. After hybridization, sections were washed for 5 min in 2× SSC, 2 min in 2× SSC/ 0.3% NP-40 at 75
• C, and 1 min in 2× SSC at room temperature. The slides air-dried at room temperature, mounted using Vectashield medium containing DAPI (Blue, Vector Laboratories) and cover slips for observation. Slides were then imaged as detailed earlier in the section on immunohistochemistry. Slides incubated with sense probe were used as negative controls.
Statistical analysis
The in vitro data presented here were derived from three independent experiments (n = 4 wells in each experiment, total of 12 wells). Data are presented as the mean ± SEM. GraphPad Prism version 5 (GraphPad Inc., IBM) was used for statistical analysis and generation of graphs. Significance was established using one-way ANOVA followed by the Tukey multiple comparison test. P ≤ 0.05 was considered statistically significant.
Results
GT1-7 and LβT2 cells express Nucb2
A band of approximately 200 base pairs representing Nucb2 sequence was detected in GT1-7 cells ( Figure 1A ) and LβT2 cells (Figure 2A ). No amplicons were detected in the negative control.
GT1-7 and LβT2 cells express nucleobindin-2/nesfatin-1 immunoreactivity
Immunofluorescence analysis showed the presence of NUCB2/nesfatin-1 in the cytoplasm of both GT1-7 ( Figure 1B ) and LβT2 ( Figure 2B and D) cells. Preabsorption of the primary antibody with 5× molar excess of the peptide resulted in complete loss of immunostaining in cells ( Figures 1E and 2E ).
GT1-7 cells and mouse hypothalamic neurons colocalize nucleobindin-2/nesfatin-1 and gonadotropin-releasing hormone immunoreactivity GT1-7 cells (Figures 1B-D) and neurons in the pre-optic area of mouse hypothalamus ( Figure 3A-D) colocalize NUCB2/nesfatin-1 and GnRH.
Nucb2 expression in mouse hypothalamus
In sections stained with the antisense probe, a distinct signal for Nucb2 was found in the hypothalamus ( Figure 4A-C) , especially in the ventromedial hypothalamus, rostral periventricular region of the third ventricle (RP3V), and in the ARC ( Figure 4B and C) of mouse brain. No signal was observed in samples hybridized with the sense probe ( Figure 4D ; negative control).
Nesfatin-1 actions on Gnrh, Kiss1r, and Esr1, and GNRH expression in GT1-7 cells
Nesfatin-1 increased Kiss1R expression at 2 and 6-h postincubation at 10 and 100 nM compared with controls at each time point ( Figure 5A ). No effect on Kiss1r expression in GT1-7 cells was found at 24 h of incubation ( Figure 5A ). Gnrh expression increased at 2 (10-100 nM), 6, and 24 h (100 nM) postincubation in GT1-7 cells ( Figure 5B ). Nesfatin-1 increased Esr1 expression at 10 and 100 nM (6 h) and 100 nM (24 h) postincubation compare with control at each time point ( Figure 5C ). GNRH expression increased at 1, 10, and 100 nM nesfatin-1 treatments ( Figure 5D ).
Nesfatin-1 regulation of LHβ mRNA/protein, Fshβ, and Gnrhr expression in LβT2 cells
Static incubation of LβT2 cells with nesfatin-1 dose-dependently upregulated both LHβ mRNA (100 nM for 6 h, and 10 and 100 nM for 24 h; Figure 6A ) and protein expression (100 nM for 6 h; Figure 6E ). Incubation of LβT2 with nesfatin-1 did not affect Gnrhr expression ( Figure 6B ). Nesfatin-1 (100 nM) significantly upregulated Esr1 expression at 6 and 24 h (Figure 6C ) of incubation. Fshβ expression was upregulated at 2 and 6 h of incubation with nesfatin-1 (100 nM) ( Figure 6D ).
Kisspeptin effects on NUCB2 mRNA and protein levels in GT1-7 and LβT2 cells
In GT1-7 cells, Nucb2 expression were increased at 1,10, and 100 nM (2 h) and 100 nM (6 and 24 h) postincubation ( Figure 7A ). Treatment of GT1-7 cells with 100 nM kisspeptin for 6 h significantly upregulated NUCB2 protein expression significantly compared with untreated controls (Figure 7B) . In LβT2 cells, kisspeptin decreased Nucb2 expression at 10 and 100 nM (6 h), and no effects were seen at 2 and 24-h postincubation ( Figure 7C ). NUCB2 protein expression was not affected by kisspeptin treatment for 6 h compared with untreated controls (Figure 7D ). Figure 1E shows a negative control that lacks NUCB2/nesfatin-1 and GnRH immunoreactivity, which was incubated only with secondary antibodies. Scale bar = 100 um. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article).
Role of GnRH on NUCB2 mRNA and protein expression in GT1-7 and LβT2 cells GnRH decreased Nucb2 at 100 nM (2 h) and increased at 100 nM (6 and 24 h) in GT1-7 cells ( Figure 8A ). NUCB2 protein levels did not change in GT1-7 cells treated with GnRH for 6 h compared with untreated controls ( Figure 8B ). GnRH decreased Nucb2 at 100 nM (2 h) and increased at 10-100 nM (6 and 24 h) ( Figure 8C ) in LβT2 cells. GnRH (1, 10, and 100 nM) increased NUCB2 protein expression more than twofold at 6-h postincubation ( Figure 8D ).
Testosterone stimulates NUCB2 mRNA and protein expression in GT1-7 and LβT2 cells Testosterone increased Nucb2 expression at 100 nM at 2 and 6-h postincubation and with 10 and 100 nM at 24-h postincubation in GT1-7 ( Figure 9A ). Western blot studies in testosterone treated GT1-7 cells for 6 h showed an immunoreactive protein band at 50 KDa corresponding to NUCB2, the nesfatin-1 precursor. Treatment of GT1-7 cells with 100 nM testosterone for 6 h upregulated NUCB2 protein expression significantly compared with untreated controls ( Figure 9B ). Testosterone enhanced Nucb2 expression at 10 and 100 nM (2 h) and 100 nM (6 and 24 h) in LβT2 cells ( Figure 9C ). Treatment of LβT2 cells with 10 nM testosterone for 6 h significantly upregulated NUCB2 protein expression compared with untreated controls ( Figure 9D ).
17β-Estradiol upregulates NUCB2 mRNA and protein expression in GT1-7 and LβT2 cells
In GT1-7 cells, 17β-estradiol enhanced Nucb2 expression at 100 nM (2 and 24 h) and 10 and 100 nM (6 h) ( Figure 10A ). Western blot showed no changes in NUCB2 content in GT1-7 cells treated with Figure 2F shows a negative control that lacks NUCB2/nesfatin-1 immunoreactivity, which was labeled only with secondary antibodies. Scale bar = 100 um. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) different concentrations at 6-h incubation ( Figure 10B ). Nucb2 was significantly increased at 100 nM E2 at 6 h ( Figure 10C ). Treatment of LβT2 cells with 10 nM E2 for 6 h significantly upregulated NUCB2 protein expression compared with untreated controls (Figure 10D) .
Discussion
This research provides novel information on the direct, reproductive hormone modulatory actions of nesfatin-1 on hypothalamic neurons and gonadotropes. We found expression of NUCB2 mRNA and protein in GnRH neurons (GT1-7 cells) and gonadotropes (LβT2 cells) in vitro. GT1-7 cells have a neuronal morphology, with neurites extending from the perikarya of cells [38] . GnRH is localized in the cytoplasm and neurites of GT1-7 cells [38] . Here we report the colocalization of nesfatin-1 and GnRH in the cytoplasm of GT1-7 cells, and neurons in mouse hypothalamus. This is the first evidence for GnRH and nesfatin-1 colocalization in mouse brain. Nesfatin-1 and GnRH are colocalized in goldfish hypothalamus [39] . Previous studies localized NUCB2/nesfatin-1 in the ARC, PVN, LHA, and SON of rat and mouse brain [25, 36, 40] . Our ISH data are the first to show cellular localization of Nucb2 in brain, and these results are consistent with previous reports that identified nesfatin-1 protein in rodent hypothalamus. Nesfatin-1 expression has been characterized Figure 3E shows a negative control that lacks NUCB2/nesfatin-1 and GnRH immunoreactivity, which was incubated only with secondary antibodies. Scale bar = 100 um.
in other cell lines, including mouse stomach ghrelinoma (MGN3-1) [41] , intestinal STC-1 cells, and insulinoma (MIN6) cells [42, 43] . Recently, nesfatin-1 binding sites were determined in the pituitary, testis, and different parts of the brain, including cortex and PVN of the hypothalamus, cerebellum, AP, and the DMN [35] . Nesfatin-1 crosses the blood-brain barrier [44] , and thus could act on GnRH neurons. Our finding that nesfatin-1 is present in GnRH neurons raises the possibility of locally produced nesfatin-1 regulating GnRH, and other brain and pituitary-derived reproductive hormones, and vice versa.
In agreement with this, stimulatory effects of nesfatin-1 on HP axis components were found in vitro. Nesfatin-1 acts directly on LβT2 cells to stimulate LHβ, and on GT1-7 cells to upregulate Kiss1r and GnRH. The concentration of circulating nesfatin-1 reported in mice and rats are 1-3 and 2-9 ng/ml [26, 32, 41] , respectively. The highest concentration used in our experiments was 1000 nM, which is equivalent to 9.5 ng/ml. In vivo studies demonstrated that the expression of NUCB2 mRNA and protein is significantly increased in the hypothalamus of female rats during puberty-to-adult transition. Fasting at puberty suppresses nesfatin-1 and decreases circulating LH levels in rats [14] . This suggests a stimulatory role for nesfatin-1 on LH. Hypophysectomy decreased NUCB2/nesfatin-1 expression, and human chorionic gonadotropin (hCG; superagonist of LH receptors) replacement increased NUCB2/nesfatin-1 expression in rat testis. Nesfatin-1 increased hCG stimulated testosterone secretion by rat testicular explants ex vivo [31] . Collectively, these results point to nesfatin-1 interactions with GnRH and gonadotropins. Similar to the above-discussed effects, GnRH caused a dual effect on Nucb2 expression in GT1-7 and LβT2 cells. At 2 h of incubation, a significant reduction in Nucb2 expression was found in both cells studied. However, at later time points tested, an increase in Nucb2 expression in response to GnRH was found. The reasons for this opposing timedependent effects currently remain unknown. It is possible that different receptors and/or receptor-mediated intracellular mechanisms mediate these time-dependent differences in GnRH effects seen here. While no changes in NUCB2 was detected in response to GnRH in neurons, a significant increase in NUCB2 matching the effects on mRNA expression was found in pituitary cells. These results suggest differential, time-dependent, and cell-specific effects for GnRH on NUCB2 transcription and translation.
We did not detect Kiss1 expression in GT1-7 cells. Terasaka et al. [45] , illustrated the presence of Kiss1 in GT1-7 cells. However, RNA sequencing data showed zero reads for Kiss1 in GT1-7 cells (Dr. Pamela Mellon, personal communication). Despite this, kisspeptin treatment upregulated NUCB2/nesfatin-1 expression in GT1-7 cells. The effect of kisspeptin on nesfatin-1 was not previously reported. Kisspeptin also upregulated GnRH secretion and Gnrh expression in a dose and time-dependent manner (Supplemental Figure S1 ), and this confirms earlier reports [46] . GT1-7 cells express both Erα and Erβ [45, 47, 48] and their expression increases upon treatment with kisspeptin [45] . Nesfatin-1 treatment in GT1-7 cells stimulated Gpr54, GnRH mRNA and protein, and Erα in our study. On the other hand, GPR54 expression and the GPR54-induced ERK1/2 signaling were enhanced by estradiol [45] . It was also reported that estrogen elicited circadian profiles of GPR54 expression in vitro possibly through ERβ action [49] . These results reveal the involvement of GPR54 in estradiol-induced GnRH secretion as a positive feedback. It also suggests that the sensitivity of GnRH to kisspeptin is partly dependent on estrogen activity. Therefore, we speculate that nesfatin-1 is a novel target of kisspeptin. Nesfatin-1 possibly interacts with kisspeptin to mediate its stimulatory effects on GnRH, and subsequently on LH secretion from pituitary cells.
We found stimulatory effects of nesfatin-1 on GnRH, Kiss1R, and LHβ, and upregulation of NUCB2/nesfatin-1 by T in cells. Luteinizing hormone stimulation of T production in Leydig cells is augmented by GnRH, and is blocked by a GnRH antagonist [50] . Nesfatin-1 increased hCG-stimulated testosterone secretion in rat testicular explants ex vivo [31] . It is possible that nesfatin-1 mediates some of the actions of brain and pituitary hormones on testosterone. Incubation of GT1-7 and LβT2 with T showed twofold and sevenfold increase in NUCB2 expression. This increase was higher than what was found for Nucb2 expression in LβT2 cells. E2 increased Gnrh and Nucb2 expression in GT1-7 cells. Estrogen stimulates Kiss1 expression in the ventromedial hypothalamus kisspeptin neurons through binding to ERα nuclear receptor [51] , which is implicated in the positive regulation of the GnRH and LH surge by E2 [52] [53] [54] [55] . E2 treatment decreases GnRH secretion in GT1-7 cells, but there is no information on Gnrh expression. Again, NUCB2 might play a role in mediating the diverse roles of E2 on neurons. Sex steroids regulate NUCB2/nesfatin-1 in mammals. In this study, testosterone stimulated NUCB2/nesfatin-1 expression in both 0, 1, 10 , 100 nM) in serum-free conditions. Nesfatin-1 upregulated GnRH mRNA expression at 10 nM (2 h) and 100 nM (2, 6, and 6 h) (A). Nesfatin-1 upregulated Kiss1R mRNA expression at 10 and 100 nM at 2 and 6 h (B). Results are shown as mean ± SEM of data from three separate experiments, each performed with four wells per treatment (n = 12). One-way ANOVA followed by Tukey multiple comparison tests was used for statistical analysis.
* P < 0.05 compared with control in each time point. Immunoblotting demonstrating that nesfatin-1 treatment promotes GnRH protein in GT1-7 cells corresponding to 10 kDa at all tested concentration (D). The relative integrated density of each protein band was digitized by image J PC-based software. Results are shown as mean ± SEM of data from at least three separate experiments, each performed with two samples. * P < 0.05 compared with control. , and 24 h with different concentrations of kisspeptin (0, 1, 10, 100 nM) in serum-free conditions. In GT1-7, kisspeptin upregulates NUCB2 at 1, 10 and 100 nM (2 h) and 100 nM (6 and 24 h) (A). In LβT2, cells kisspeptin downregulates NUCB2 at 10 nM (2 h) and at 10 and 100 nM (6 h) (C). Total cellular RNA was extracted, and mRNA levels were examined by real-time RT-PCR. The expression levels of target genes were normalized by beta-actin level in each sample. Results are shown as mean ± SEM of data from three separate experiments, each performed with four wells per treatment (n = 12). One-way ANOVA followed by Tukey multiple comparison tests was used for statistical analysis. * P < 0.05 compared with control in each time point.
GT1-7 and LβT2 cells. E2 upregulated NUCB2/nesfatin-1 expression in GT1-7 cells. Treatment of mouse cultured pituitary explants with estradiol and progesterone significantly increased and decreased Nucb2 expression, respectively [56] , which is consistent with our result in LβT2 cell. Also, it was reported that NUCB2 decreased after ovariectomy, and rapidly increased in the pituitary gland of mice after intraperitoneal injection of progesterone alone, estradiol alone, or both combined [56] . Recent studies by Kiss cell-specific ERα knockout mice demonstrated the necessity of ERα for the induction of Kiss1 and GnRH/LH surge by E2 [51, 57] . The upregulation of Erα by nesfatin-1 in GT1-7 cells seen in our studies further supports the stimulatory effect of nesfatin-1 on GPR54/GnRH/LH signaling. It was shown that fluctuations in testosterone levels during puberty affect NUCB2/nesfatin-1 synthesis in rats [28] . In addition, in delayed weaning rats, circulating testosterone is lower than their age-matched controls, and at puberty, circulating levels of nesfatin-1 , and 24 h with different concentrations of GnRH (0, 1, 10, 100 nM) in serum-free conditions. GnRH downregulates NUCB2 at 100 nM (2 h) and upregulates NUCB2 mRNA expression at 100 nM (2 and 6 hs) in GT1-7 (A). In LβT2, GnRH downregulates and upregulates NUCB2 at 100 nM (2 h) and 10 and 100 nM (6 and 24 h), respectively (C). Results are shown as mean ± SEM of data from three separate experiments, each performed with four wells per treatment (n = 12). One-way ANOVA followed by Tukey multiple comparison tests was used for statistical analysis. * P < 0.05 compared with control in each time point. Immunoblotting demonstrating that GnRH treatment promotes NUCB2 protein in LβT2 cells corresponding to 50 kDa at all tested concentration. The relative integrated density of each protein band was digitized by image J PC-based software. Results are shown as mean ± SEM of data from at least three independent experiments, each performed with two samples (n = 6). * P < 0.05 compared with control.
is positively correlated with testosterone [27, 28] . This is consistent with our in vitro results where T was found to stimulate nesfatin-1 mRNA and protein expression in hypothalamic neurons and gonadotropes. Estrogen stimulates Lhβ response to GnRH in LβT2 cells [58, 59] . In LβT2 cells, E2 enhances GnRH stimulation of Egr-1, which is critical for LHβ expression and suppresses the expression of Zfhx1a (a zinc finger homeodomain protein that acts as a transcriptional repressor) without affecting Gnrhr [58] . In agreement with the stimulatory effect of E2 on LHβ response to GnRH, we observed increase of LHβ after 6-h treatment with 100 nM E2 (data not shown), which corresponded an increase in NUCB2 mRNA and protein expression in LβT2. This suggests synergetic action of nesfatin-1 and E2 to regulate LHβ. ERa is responsible for both negative and positive feedback effects of E2 on LH synthesis and secretion. Pituitary and plasma LH levels are higher in ERa knockout female Figure 9 . NUCB2 mRNA expression (A, C) and NUCB2/nesfatin-1 protein expression (B, D) from GT1-7 and LβT2 cells incubated for 2, 6, and 24 h with different concentrations of testosterone (0, 1, 10, 100 nM) in serum-free conditions. In GT1-7, testosterone upregulates NUCB2 at 100 nM (2 and 6 h) and 10 and 100 nM in 24 h (A). In LβT2, testosterone upregulates NUCB2 at 10 and 100 nM (2 h) and at 100 nM (6 and 24 h) (C). Total cellular RNA was extracted and mRNA levels were examined by real-time RT-PCR. The expression levels of target genes were normalized by Beta-actin level in each sample. Results are shown as mean ± SEM of data from three separate experiments, each performed with four wells per treatment (n = 12). One-way ANOVA followed by Tukey multiple comparison tests was used for statistical analysis.
* P < 0.05 compared with control in each time point. Immunoblotting demonstrating that testosterone treatment promotes NUCB2 protein in GT1-7 cells corresponding to 50 kDa. Testosterone increases the NUCB2 protein at 100 nM 6-h postincubations (B). In LβT2, immunoblotting demonstrating that testosterone treatment promotes NUCB2 protein in LβT2 cells corresponding to 50 kDa. Testosterone increases the NUCB2 protein at 10 nm 6-h postincubation in LβT2 (D). The relative integrated density of each protein band was digitized by image J PC-based software. Results are shown as mean ± SEM of data from at least three independent experiments, each performed with two samples (n = 6). * P < 0.05 compared with control. , and 24 h with different concentrations of 17β-Estradiol (0, 1, 10, 100 nM) in serum-free conditions. E2 upregulates NUCB2 at 100 nM (2, 6, and 24 h) (A). In LβT2, E2 upregulates NUCB2 at 100 nM at 6-h postincubation (C). Results are shown as mean ± SEM of data from three separate experiments, each performed with four wells per treatment (n = 12). One-way ANOVA followed by Tukey multiple comparison tests was used for statistical analysis. * P < 0.05 compared with control in each time point.
Immunoblotting demonstrating that E2 did not affected NUCB2 protein in GT1-7 (B). E2 increase the NUCB2 protein at 10 nM in LβT2 cells corresponding to 50 kDa. (D) The relative integrated density of each protein band was digitized by image J PC-based software. Results are shown as mean ± SEM of data from at least three independent experiments, each performed with two samples (n = 6). * P < 0.05 compared with control.
mice compared to wild types despite having higher level of E2. This points to a critical role for ERa in negatively regulating LH synthesis and secretion in vivo via the hypothalamus. In contrast, E2 enhances GnRH-induced LH secretion in primary pituitary cultures of female wild-type mice in vitro, and this effect was lacking in ERa KO gonadotropes. This suggests that the stimulatory effects of E2 on LHβ in the pituitary are dependent on the presence of ERa [60] .
The latter result is in agreement with our finding that both E2 and nesfatin-1 treatment increased Era expression in LβT2 cells. This coincided with an upregulation of LHβ mRNA and protein expression in gonadotropes.
In conclusion, and as hypothesized, nesfatin-1 acts directly on neurons and gonadotropes. Nesfatin-1 has positive effects on reproductive hormones (Figure 11 ). Reproductive hormones, in turn, modulate NUCB2 mRNA and protein expression in the hypothalamus and pituitary cells (Inset table in Figure 11 ). Nesfatin-1 stimulates LH secretion by possibly modulating GPR54/GnRH systems in the hypothalamus. Nesfatin-1 directly modulates LHβ expression in LβT2 gonadotropes. Overall, these results support a stimulatory role for nesfatin-1 on the endocrine milieu regulating reproduction in mice. We demonstrated for the first time that kisspeptin stimulates NUCB2/nesfatin-1 expression in the hypothalamic neuronal cell lines and vice versa. On the other hand, nesfatin-1 directly stimulates GnRH mRNA and protein. This result illustrates that nesfatin-1 could mimic the role of kisspeptin to stimulate GnRH secretion and lead to gonadotropin synthesis and secretion in gonadotropes in the pituitary that is consistent with our results in pituitary cells. Next line of inquiries should explore whether the actions found in vitro holds true in vivo in mice. Further studies on the receptor-mediated signaling are needed to elucidate the detailed mechanism of nesfatin-1 action. Collectively, we provide more evidence to assign NUCB2 and nesfatin-1 as novel, additional players that help reproductive success.
Supplementary data
Supplementary data are available at BIOLRE online. Figure S1 . Gnrh expression in GT1-7 cells Incubated for 2, 6, and 24 h with different concentrations of kisspeptin (0, 1, 10, 100 nM) in serum-free conditions. Kisspeptin upregulates Gnrh at 1,10, and 100 nM (2 h) and 100 nM (6 h) doses. Results are shown as mean ± SEM of data from three separate experiments, each performed with four wells per treatment (n = 12 wells from three experiments). One-way ANOVA followed by Tukey's multiple comparison tests was used for statistical analysis.
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* P < 0.05 compared with control in each time point.
